GlassScriptPhysician profile
Brandy L Scott
NPI 1881229474
$6,935.56
in general payments reported to CMS, 2019-2025
27 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what 90% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $571 · 2022: $896 · 2023: $1,707 · 2024: $2,011 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,469.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $1,127.57 | 2022-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $979.34 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Lundbeck LLC | $743.34 | 2021-2025 | Rexulti, Abilify Maintena |
| Abbvie INC. | $656.61 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $611.28 | 2022-2025 | Spravato, Invega Sustenna |
| Neurocrine Biosciences, INC. | $419.12 | 2021-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $394.54 | 2022-2025 | Fanapt, Hetlioz |
| Corium, LLC | $393.14 | 2022-2025 | Azstarys |
| Alkermes, INC. | $284.48 | 2023-2024 | Aristada, Aristada Initio, Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $275.56 | 2021-2025 | Trintellix |
| Idorsia Pharmaceuticals US INC | $213.80 | 2022-2024 | Quviviq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $189.51 | 2023-2025 | Caplyta |
| Bausch Health US, LLC | $88.37 | 2021-2023 | Aplenzin, Wellbutrin |
| Almatica Pharma LLC | $84.15 | 2022-2025 | Loreev Xr |
| Ironshore Pharmaceuticals INC. | $82.52 | 2022-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $72.62 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $69.86 | 2022-2023 | Adzenys Xr-Odt |
| Sage Therapeutics, LLC | $39.58 | 2025 | Zurzuvae |
| Teva Pharmaceuticals USA, INC. | $39.05 | 2025 | Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $26.81 | 2025 | Cobenfy |
| Livanova USA, INC. | $24.64 | 2024 | Vns Therapy Symmetry Model 8103 Generator |
| Noven Therapeutics, LLC | $22.60 | 2024 | Secuado, Xelstrym |
| Eisai INC. | $21.62 | 2021 | |
| Indivior INC. | $20.80 | 2023 | Perseris |
| Tris Pharma INC | $20.75 | 2024 | |
| Avanir Pharmaceuticals, INC. | $20.61 | 2022 | |
| Merck Sharp & Dohme LLC | $13.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.